hypofractionated radiation

RADIATION8 trials

Conditions

Breast CancerEarly Stage Prostate CancerEndometrial CancerGliomaMaximum Tolerated DoseNode-positive Breast CancerProstate CancerRadiotherapy, Intensity-Modulated

Phase 1

Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer

NCT01505075

Sunnybrook Health Sciences CentreProstate Cancer

Start: 2011-09-30End: 2021-09-30Target: 30Updated: 2020-11-24

RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy

WithdrawnNCT02880345

Abramson Cancer Center at Penn MedicineUrothelial Cancer

Start: 2016-08-31End: 2018-12-31Updated: 2019-04-23

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

SuspendedNCT04683653

University of ChicagoEndometrial Cancer

Start: 2021-01-15End: 2026-12-20Target: 100Updated: 2026-09-10

Phase 2

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

RecruitingNCT06559540

Washington University School of MedicineNode-positive Breast Cancer

Start: 2024-08-27End: 2034-04-30Target: 220Updated: 2026-01-09

Unknown Phase

Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial

CompletedNCT03082846

Xue XiaoyingGlioma, Maximum Tolerated Dose, Radiotherapy, Intensity-Modulated

Start: 2014-01-01End: 2016-12-03Updated: 2017-03-21

Ultra-hypofractionated Radiation in Prostate Cancer

CompletedNCT03486821

University of Kansas Medical CenterEarly Stage Prostate Cancer

Start: 2018-03-22End: 2026-03-02Updated: 2026-05-05

RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam

NCT05486936

Ruijin HospitalBreast Cancer

Start: 2021-12-15End: 2024-12-15Target: 195Updated: 2022-08-04

Hypofractionated Regional Nodal Irradiation in Breast Cancer

Active, not recruitingNCT06443359

Corewell Health EastBreast Cancer

Start: 2018-11-13End: 2027-07-01Updated: 2026-04-20

Related Papers

RT-PACE: Phase I/II study of adjuvant whole pelvic hypofractionated radiotherapy for non-metastatic cervical and endometrial cancer.

Journal of Clinical Oncology2023-06-012 citations

SABR in high-risk prostate cancer: Outcomes from two prospective clinical trials with and without elective nodal irradiation.